Prevalence of COPD patients with signs of asthma according to Dutch GP guidelines

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/28945
• EU PAS number:
  EUPAS27806
• Study ID:
  28945
• Official title and acronym:
  Prevalence of COPD patients with signs of asthma according to Dutch GP guidelines
• DARWIN EU® study:
  No
• Study countries:
  Netherlands
• Study description:
  Aims to describe the prevalence of asthma characteristics, like history of asthma/atopy, symptom pattern or reversibility, in patients with a pulmonologist confirmed working diagnosis of COPD or ACO. The primary outcome of this study is the percentage of COPD and ACO patients with asthma characteristics and in addition to that, the percentage of COPD and ACO patients which have no, one, two and three or more asthma characteristics is examined. Additionally, the percentage of asthma characteristics in COPD/ACO patients who have a blood eosinophil count of ≤150 cells per µL, between 151-300 cells per µL or >300 per µL is examined.
• Study status:
  Ongoing

Research institutions and networks

Institutions

General Practitioners Research Institute (GPRI)

Netherlands

Study timelines

Date when funding contract was signed

Actual: 08/01/2019

Study start date

Planned: 08/02/2019

Actual: 08/02/2019

Date of final study report

Planned: 01/06/2019

Sources of funding

Pharmaceutical company and other private sector 

Other

More details on funding

GlaxoSmithKline, General Practice Research Institute

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable